F-group (family)
7512.1.1.1 UDPGT
Ligands and drugs
1,335
Member domains
230
with ligand contacts (≤ 4 Å)
17.2% of members
140
with DrugDomain annotations
10.5% of members
131
with a DrugBank compound
9.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7512.1.1.1 belongs to X-group 7512 UDP-Glycosyltransferase/glycogen phosphorylase, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03435 | UDP | Uridine-5'-Diphosphate | 71 |
| DB03488 | U2F | Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose | 15 |
| DB09459 | TLA | L-tartaric acid | 12 |
| DB01861 | UPG | Uridine diphosphate glucose | 11 |
| DB02379 | BGC | Beta-D-Glucose | 11 |
| DB01852 | KMP | Kaempherol | 6 |
| DB04216 | QUE | Quercetin | 5 |
| DB00936 | SAL | Salicylic acid | 4 |
| DB02709 | STL | Resveratrol | 3 |
| DB17939 | 3RL | Pterostilbene | 3 |
| DB03467 | NAR | Naringenin | 2 |
| DB04177 | DTX | Digitoxigenin | 2 |
| DB04552 | — | Niflumic acid | 2 |
| DB04824 | — | Phenolphthalein | 2 |
| DB07810 | G50 | Phloretin | 2 |
| DB07992 | IOS | Indoxyl sulfate | 2 |
| DB16859 | ZWN | Naringin | 2 |
| DB00130 | GLN | L-Glutamine | 1 |
| DB01713 | UDX | UDP-alpha-D-xylose | 1 |
| DB02375 | MYC | Myricetin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| UDP | URIDINE-5'-DIPHOSPHATE | 133 |
| U2F | URIDINE-5'-DIPHOSPHATE-2-DEOXY-2-FLUORO-ALPHA-D-GLUCOSE | 24 |
| UPG | URIDINE-5'-DIPHOSPHATE-GLUCOSE | 20 |
| BGC | beta-D-glucopyranose | 12 |
| TLA | L(+)-TARTARIC ACID | 12 |
| T83 | 7-hydroxy-6-methoxy-2H-1-benzopyran-2-one | 8 |
| KMP | 3,5,7-TRIHYDROXY-2-(4-HYDROXYPHENYL)-4H-CHROMEN-4-ONE | 7 |
| 7WV | 2-bromobenzoic acid | 6 |
| A1L68 | (2~{S},4~{a}~{S},6~{a}~{R},6~{a}~{S},6~{b}~{R},8~{a}~{R},10~{S},12~{a}~{R},14~{b}~{R})-2,4~{a},6~{a},6~{b},9,9,12~{a}-heptamethyl-10-oxidanyl-13-oxidanylidene-3,4,5,6,6~{a},7,8,8~{a},10,11,12,14~{b}-dodecahydro-1~{H}-picene-2-carbothioic S-acid | 4 |
| BMA | beta-D-mannopyranose | 4 |
| BR | BROMIDE ION | 4 |
| QUE | 3,5,7,3',4'-PENTAHYDROXYFLAVONE | 4 |
| SAL | 2-HYDROXYBENZOIC ACID | 4 |
| 6JI | 5-[(1R,2S,4R,6R,7R,10S,11S,14S,16R)-14-hydroxy-7,11-dimethyl-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-6-yl]pyran-2-one | 3 |
| DTX | DIGITOXIGENIN | 3 |
| STL | RESVERATROL | 3 |
| 3RL | Pterostilbene | 2 |
| 8YG | Ginsenoside Rh2 | 2 |
| AQ9 | 1-O-[(8alpha,9beta,10alpha,13alpha)-13-(beta-D-glucopyranosyloxy)-18-oxokaur-16-en-18-yl]-beta-D-glucopyranose | 2 |
| AUO | (8alpha,9beta,10alpha,13alpha)-13-{[beta-D-glucopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->3)]-beta-D-glucopyranosyl]oxy}kaur-16-en-18-oic acid | 2 |